Science Explorer Back to mapMap
Discussion
Researcher · CHU Dijon Bourgogne · France

Marc Maynadié

Marc Maynadié publishes mostly in Hematology, Pathology and Forensic Medicine and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research and Acute Lymphoblastic Leukemia research.

ORCID 0000-0002-6823-2583 OpenAlex
World rank
#305,867
of 7,710,434 ranked researchers
Rank in France
#17,701
of 324,115
Works
352
Citations
21k
Citations per work
58.7
h-index
65
i10-index 141Top 1.6% in Hematology
Marc Maynadié

What does Marc Maynadié research?

Marc Maynadié's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 178 works · 50.5% of their workMedicine: 178 works · 50.5% of their workHematology: 49 works · 14.0% of their workPathology and Forensic Medicine: 42 works · 11.9% of their workOncology: 37 works · 10.4% of their workGenetics: 29 works · 8.3% of their workPublic Health, Environmental and Occupational Health: 21 works · 5.9% of their workEverything else: 154 works · 43.7% of their workLife Sciences: 20 works · 5.8% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 5.8% of their workMolecular Biology: 20 works · 5.8% of their workTHEIR WORKMarc Maynadié352works
Life Sciences6%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine17850.5%
  2. Everything else15443.7%
    1. Biochemistry, Genetics and Molecular Biology205.8%
  1. 1Hematology14% of their works
  2. 2Pathology and Forensic Medicine12% of their works
  3. 3Oncology10% of their works
  4. 4Genetics8% of their works
  5. 5Public Health, Environmental and Occupational Health6% of their works
  6. 6Molecular Biology6% of their works

Research topics

Which keywords describe Marc Maynadié's research?

The keywords of their largest research topics: Prognostic Factors, Rituximab, Classification, Lymphoma, Minimal Residual Disease, Acute Myeloid Leukemia, AML and Acute Lymphoblastic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors1373 topics
  2. Rituximab1252 topics
  3. Classification881 topic
  4. Lymphoma881 topic
  5. Minimal Residual Disease612 topics
  6. AML561 topic
  7. Acute Myeloid Leukemia561 topic
  8. Acute Lymphoblastic Leukemia441 topic
  9. Childhood Cancer441 topic
  10. Cancer Incidence422 topics
  11. Chronic Lymphocytic Leukemia371 topic
  12. Genomic Aberrations371 topic
  13. Multiple Primary Cancers221 topic
  14. Second Primary Neoplasms221 topic
  15. JAK2 Mutation211 topic
  16. Myelofibrosis211 topic
  17. Epstein-Barr Virus201 topic
  18. Kaposi's Sarcoma201 topic
  19. Diagnosis Criteria171 topic
  20. International Myeloma Working Group171 topic

Where does Marc Maynadié work?

Marc Maynadié's main affiliation in the publication record is CHU Dijon Bourgogne, France.

How many publications and citations does Marc Maynadié have?

OpenAlex counts 352 works and 20,663 citations for Marc Maynadié, an h-index of 65, ranking #305,867 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Marc Maynadié

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marc Maynadié. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.